As an antiviral medication used to treat cytomegalovirus retinitis, also known as CMV in patients infected with the HIV virus, the current Cidofovir shortage is alarming (see the FDA Cidofovir shortage posting). Administered as an injectable treatment intravenously, the dosing of Cidofovir can take up to six hours to complete. The treatment of 75 mg/ml[…]
Cidofovir Shortage Affects HIV Positive Patients with Cytomegalovirus Retinitis
Anti-Retroviral / Anti-HIV, Antiviral, Drug Research & Development API, FDA Drug Shortage Tags: HIV virus Nov 06, 2013
Aminocaproic Acid Shortage is Concerning for Surgical and Trauma Centers
FDA Drug Shortage, OTC and Compounding Product Oct 23, 2013
The current shortage of the Aminocaproic Acid injection, 250 mg/mL, 20 mL vial has patients with bleeding disorders and post-surgical patients quite concerned. This injection is crucial for controlling bleeding when blood clots are broken down overly quickly, which occurs often after heart, liver or other surgery, as well as for people who have certain[…]
Shortage of Buprenorphine Affects Patients in Need of Pain Management and in Detoxification Programs
Analgesic, FDA Drug Shortage, OTC and Compounding Product, TEVA API Oct 17, 2013
The current shortage of the narcotic analgesic Buprenorphine CAS# 52485-79-7, also known as the brand name Buprenex, has created a significant concern. As an injectable medication administered to treat moderate to severe pain, Buprenorphine is not only used for pain management, it is also used to treat addiction to narcotic drugs through a rapid detoxification[…]
Drug Shortages Loom as Obamacare Commences
Drug Research & Development API, FDA Drug Shortage, LGM Pharma, OTC and Compounding Product, TEVA API Oct 15, 2013
Drug shortages continue to worry healthcare industry workers, especially with the launch of Obamacare on October 1, 2013. While notification has been prompt from the FDA as to which drugs are in danger of becoming in short supply, many medications which are already minimally available have not seen a respite. Falling Short The once planned[…]
Fentanyl Shortage Creates a Painful Situation
Anesthetic, FDA Drug Shortage, Patent Expiration 2018, Patent Expiration 2019 Oct 04, 2013
As a rapid acting pain medication, Fentanyl is an efficacious and tolerable treatment for moderate to severe pain. The news on August 26, 2013 of a continued shortage of this pain relieving remedy has created concern among the medical community. Emergency medical services are proponents of the use of Fentanyl over morphine for pain, as[…]
Midazolam Shortage Affects Medical and Veterinary Communities
Anesthetic, FDA Drug Shortage, OTC and Compounding Product Oct 01, 2013
Midazolam is an effectual benzodiazepine, regularly used for humans and animals as part of a pre-surgical regimen. As a pre-anesthetic agent, Midazolam is typically used to help ease anxiety before surgical procedures, and induce amnesia so patients will essentially forget any uncomfortable thoughts regarding their preparation and pending surgery. Pets are often dispensed Midazolam alongside[…]
Shortage of Acyclovir Leads to Dire Situation for Patients with Encephalitis
Anti-Retroviral / Anti-HIV, Antiviral, Drug Research & Development API, FDA Drug Shortage, OTC and Compounding Product, Patent Expiration 2017 Sep 18, 2013
The current shortage of Acyclovir, CAS number 59277-98-3, is of great concern to the medical community. As a valued and integral treatment for encephalitis, the shortage of Acyclovir for compounding pharmacies has created an urgent need for both patients and practitioners. The August 27, 2013 issue of the Neurology journal cautioned healthcare professionals to be[…]
Shortage of Tobramycin Affects Many
Antibiotic, Drug Research & Development API, FDA Drug Shortage, OTC and Compounding Product Tags: antibioticcystic fibrosis Sep 13, 2013
As an aminoglycoside antibiotic effective for treating a wide variety of infections, Tobramycin CAS# 32986-56-4 is an integral medication that affects a vast number of patients. Tobramycin is particularly effectual for treating Gram-negative infections and certain Pseudomonas. The recent shortage of this crucial antibiotic has been felt for patients who take Tobramycin, either as an[…]
